Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG

Mertlíková-Kaiserová, Helena - Rumlová, Michaela - Tloušťová, Eva - Procházková, Eliška - Holý, Antonín - Votruba, Ivan
Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG.
Biochemical Pharmacology. Roč. 82, č. 2 (2011), s. 131-138. ISSN 0006-2952. E-ISSN 1873-2968
Impakt faktor: 4.705, rok: 2011
http://hdl.handle.net/11104/0198197